longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Berkshire Hathaway spent USD 106 million to increase its stake in Sirius XM and reduced its holdings in DaVita, cashing out USD 230 million

Zhitong
Aug 5, 2025 at 07:03 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Berkshire Hathaway increased its holdings in Sirius XM stock by approximately $106 million, raising its stake to over 124.8 million shares. At the same time, it reduced its holdings in DaVita stock, cashing out approximately $230 million. This move may reflect its strategy to increase investments in media and technology assets

According to the Zhitong Finance APP, regulatory documents show that Berkshire Hathaway (BRK.A.US), led by Warren Buffett, has increased its holdings in Sirius XM (SIRI.US) stock worth approximately $106 million. The documents indicate that Berkshire Hathaway purchased 5,030,425 shares of Sirius XM common stock in a series of transactions from July 31 to August 4, 2025, raising its total holdings to over 124.8 million shares.

It is reported that Sirius XM is a North American radio entertainment company that provides live and curated services through satellite broadcasting, offering content such as music, sports, drama, talk shows, and news, primarily maintaining stable profits through in-car scenarios. Previous analyses have pointed out that Berkshire Hathaway's repeated increases in Sirius XM holdings may reflect the company's strategy to enhance its media and technology asset portfolio.

In addition, another regulatory document shows that Berkshire Hathaway sold 1,635,962 shares of dialysis service provider DaVita (DVA.US) at a price of $140.6, cashing out approximately $230 million. Notably, Berkshire Hathaway had previously reduced its holdings in DaVita multiple times, including a sale of 200,000 shares in May this year, cashing out $27.8 million.

It is reported that DaVita is a company that provides dialysis services for patients with kidney failure. The company does not manufacture dialysis medications or medical devices, focusing solely on providing dialysis services. Berkshire Hathaway has repeatedly increased its holdings in DaVita stock in the secondary market since 2012, holding 42.25% of the company as of March 31 of this year

Login to unlock1,166characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 9, 2026 at 11:04 AMWith AMZN on board, is QCOM's AI second S-curve locked in?
  • Sep 9, 2026 at 08:25 AMWarren Buffett and His Successor, Greg Abel, Have Piled More Than $82 Billion Into This Perennial Winner (No, Not Alphab…
  • Sep 7, 2026 at 10:46 PMWarren Buffett Told CNBC 'I Initiated It' About Berkshire's Alphabet Bet, and New Reporting Says He's Still Calling the …
  • Sep 7, 2026 at 07:00 PMBerkshire Hathaway Owns AI Exposure in 3 Different Ways. Here's Why That's Not the Same as Owning Nvidia.
  • Sep 7, 2026 at 01:05 PMNot Nvidia, Not Micron. This Magnificent Warren Buffett Stock Could Be the Quiet Winner of the AI Arms Race -- Here's th…

Related Stocks

DaVita

DaVita

USDVA

+1.64%

Berkshire Hathaway B

Berkshire Hathaway B

USBRK.B

+0.18%

Berkshire Hathaway

Berkshire Hathaway

USBRK.A

+0.18%

LongbridgeAI